Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
Impact of Epilepsy on Productivity and Quality of Life: The Australian Epilepsy Project
Gopisankar Mohanannair Geethadevi1, Zhibin Chen2, Emma Foster2,3
1Health Economics and Policy Evaluation Research Group, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Melbourne, VIC, Australia.
Background And Objectives:
Epilepsy occurs in 4% of Australians over their lifetime. European studies show that over 75% of epilepsy-related health care costs are indirect, with 80% due to absenteeism. In Australia, studies capturing absenteeism in epilepsy are limited and presenteeism data are unavailable. This study investigated employment rates, absenteeism, presenteeism, and quality of life reported by people who experienced seizures in Australia.
Methods:
The Australian Epilepsy Project (AEP) is a prospective cohort study of adults with first unprovoked seizure (FUS), newly diagnosed epilepsy (NDE), or focal drug-resistant epilepsy (DRE), referred mainly from tertiary care clinics. This study is a cross-sectional analysis of AEP baseline data, reporting quality of life (EuroQol 5 Dimensions [EQ-5D-5L] and Quality of Life in Epilepsy Inventory [QOLIE-31]); employment rates; and the prevalence and extent of absenteeism and presenteeism, assessed using the Work Productivity and Activity Impairment questionnaire. Correlations were assessed using either Spearman or Pearson methods. Logistic regression was used for odds.
Results:
Of 670 participants (median age 35.6 years, interquartile range [IQR] 26.9-47.3 years, 53.4% female participants), 15.9% had FUS, 34.6% had NDE, and 49.4% had DRE. The median (IQR) EQ-5D-5L score for the cohort was 0.93 (0.83-0.96). The mean QOLIE-31 score was lower for people with DRE (49.7 ± 16.8), compared with both NDE (57.9 ± 17.4, p = 0.003) and FUS (59.4 ± 16.2, p = 0.003) groups. The employment rate was 62.3% (95% CI 58.4%-66.1%), with lower rates in the DRE group (53.9% p < 0.001). 30.8% (95% CI 26.1%-35.7%) of workers reported absenteeism, 45% (95% CI 40.0%-50.0%) reported presenteeism, and 23% (95% CI 19.6%-28.5%) reported both. Among those with absenteeism, each year, full-time workers lost a median of 60 (IQR 31.5-189.4) days of work and part-time workers lost 37.8 (IQR 18.9-75.7) days of work. The mean percentage of presenteeism was higher in patients with DRE compared with those with NDE (22.9% vs 15.2%, p = 0.007). People with absenteeism and presenteeism had lower QOLIE-31 scores (mean difference -9.9, 95% CI -6.4 to -13.3, p < 0.001; -9.2, 95% CI -0.016 to -0.076, p < 0.001) than those without.
Discussion:
Employment and work productivity are commonly reduced in people who experience seizures, particularly those with DRE. Lower productivity was associated with poorer quality of life. Further studies are needed to understand the nature of this relationship.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Electroconvulsive Therapy

